Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
TRPM2 Biologics Sequence Review Report 2026: Transient receptor potential cation channel subfamily M member 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TRPM2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
C3 Biologics Sequence Review Report 2026: Complement C3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of C3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PLXNB1 Biologics Sequence Review Report 2026: Plexin-B1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PLXNB1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
NCAM1 Biologics Sequence Review Report 2026: Neural cell adhesion molecule 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of NCAM1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
MRC1 Biologics Sequence Review Report 2026: Macrophage mannose receptor 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MRC1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
MS4A1 Biologics Sequence Review Report 2026: B-lymphocyte antigen CD20 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MS4A1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
LY6G6C Biologics Sequence Review Report 2026: Lymphocyte antigen 6 complex locus protein G6c Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LY6G6C protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
LRP6 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 6 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LRP6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
LY6G6D Biologics Sequence Review Report 2026: Lymphocyte antigen 6 complex locus protein G6d Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LY6G6D protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
LRP4 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LRP4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
LRP5 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LRP5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
INSR Biologics Sequence Review Report 2026: Insulin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of INSR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.